Transmyocardial laser revascularisation and other treatment modalities for angina pectoris

被引：2
|
作者：
Huikeshoven, M
van der Sloot, JAP
Tukkie, R
Beek, JF
机构：
[1] Univ Amsterdam, Acad Med Ctr, Ctr Laser, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands
来源：
LASERS IN MEDICAL SCIENCE | 2003年 / 18卷 / 01期
关键词：
angina pectoris; angiogenesis; denervation; perfusion; refractory; treatment;
D O I：
10.1007/s10103-002-0253-3
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
Ischaemic heart disease is one of the leading causes of morbidity and mortality in the western world. This paper provides an overview of the different treatments for one of the most common manifestations of ischaemic heart disease: angina pectoris. Besides the currently available conventional methods, several alternative treatments are described, with a special focus on transmyocardial laser revascularisation.
引用
收藏
页码：2 / 11
页数：10
相关论文
共 50 条
  • [1] Transmyocardial laser revascularisation and other treatment modalities for angina pectoris
    M. Huikeshoven
    J. A. P. van der Sloot
    R. Tukkie
    J. F. Beek
    Lasers in Medical Science, 2003, 18 : 2 - 11
  • [2] Mid-term prognosis after transmyocardial laser revascularization compared to other treatment modalities in patients with refractory angina pectoris
    Maisch, B
    Funck, R
    Herzum, M
    Hoeffken, H
    Simon, B
    Menz, V
    Ristic, AD
    Rybinski, L
    Joseph, K
    Moosdorf, R
    EUROPEAN HEART JOURNAL, 2000, 21 : 85 - 85
  • [3] Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial
    Burkhoff, D
    Schmidt, S
    Schulman, SP
    Myers, J
    Resar, J
    Becker, LC
    Weiss, J
    Jones, JW
    LANCET, 1999, 354 (9182): : 885 - 890
  • [4] NICE evaluation of transmyocardial laser revascularisation and percutaneous laser revascularisation for refractory angina
    Schofield, P. M.
    McNab, D.
    HEART, 2010, 96 (04) : 312 - 313
  • [5] A cost-utility analysis comparing transmyocardial laser revascularisation to standard medical management for patients with refractory angina pectoris
    Campbell, H
    Tait, S
    Burton, M
    Sharples, L
    Caine, N
    Schofield, PM
    Wallwork, J
    EUROPEAN HEART JOURNAL, 2000, 21 : 222 - 222
  • [6] Transmyocardial laser revascularisation in patients with refractory angina: A randomised controlled trial
    Schofield, PM
    Scharples, LD
    Caine, N
    Burns, S
    Tait, S
    Wistow, T
    Buxton, M
    Wallwork, J
    HERZ KREISLAUF, 1999, 31 (06): : 224 - 224
  • [7] Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial
    Schofield, PM
    Sharples, LD
    Caine, N
    Burns, S
    Tait, S
    Wistow, T
    Buxton, M
    Wallwork, J
    LANCET, 1999, 353 (9152): : 519 - 524
  • [8] Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial
    Oesterle, SN
    Sanborn, TA
    Ali, N
    Resar, J
    Ramee, SR
    Heuser, R
    Dean, L
    Knopf, W
    Schofield, P
    Schaer, GL
    Reeder, G
    Masden, R
    Yeung, AC
    Burkhoff, D
    LANCET, 2000, 356 (9243): : 1705 - 1710
  • [9] Transmyocardial revascularisation for refractory angina: the debate continues
    Ahmad, K
    LANCET, 1999, 354 (9186): : 1271 - 1271
  • [10] Transmyocardial laser revascularisation - Reply
    Schofield, PM
    Sharples, LD
    Caine, N
    Buxton, M
    Wallwork, J
    LANCET, 1999, 353 (9165): : 1706 - 1707
12345